Overview
Background
Profile Summary
Dr Sandro Porceddu is an internationally recognised radiation oncologist and a leading authority in head and neck and skin cancer. With over 20 years experience in medicine his areas of clinical expertise include head and neck cancer, skin cancer, sarcoma and lymphoma. He is currently a senior radiation oncologist and Director of radiation oncology research at the Princess Alexandra Hospital, Brisbane, Professor of Medicine, University of Queensland and Associate Editor for the International Head and Neck journal, Oral Oncology.
Dr Porceddu is a nationally and internationally recognised cancer advocate through his involvement in high-level committees, engagement with key policymakers, community education and media roles.
Career Summary
Professor Porceddu completed his medical degree at Monash University before undertaking his residency at Monash Medical Centre, Melbourne. He commenced his specialist training in radiation oncology at the Peter MacCallum Cancer Centre in 1996 and was made Fellow of the Royal Australian and New Zealand College of Radiologists, Faculty of Radiation Oncology in 2000. After working as a consultant radiation oncologist at PeterMac for several years he moved to the Princess Alexandra Hospital in 2004.
Professional Committees and Organisations
Professor Porceddu has been the President of the Clinical Oncology Society of Australia (COSA), the peak organisation for cancer-related health professionals, and the Trans Tasman Radiation Oncology Group (TROG), one of the largest cancer collaborative trials group in Australia/New Zealand. He has served on numerous national and international professional and academic committees including the board of the Cancer Council of Australia, the National Cancer Expert Reference Group for the Commonwealth and the International Union for the Control of Cancer (UICC) TNM Expert Advisory Panel.
Currently, he is the Chair of the Cancer Council Queensland Co-operative Oncology Group, a committee that provides over $1.2M per annum to support clinical research throughout Queensland and is on the board of the of the Head and Neck Cancer InterGroup (HNCIG), a group of leading world cancer experts dedicated to promoting the global harmonisation of head and neck cancer research and treatment.
Academic Highlights
Professor Porceddu runs an active clinical research program with over 150 peer-review articles, book chapters, published abstracts, invited reviews and commentaries. He has received invitations to speak at major international conferences such as the American Society of Clinical Oncology (ASCO) meeting and publish in prestigious journals such as the Lancet Oncology and Journal of Clinical Oncology.
Awards
Trans Tasman Radiation Oncology Group Outstanding Contribution
American Head and Neck Society Chris O’Brien Travelling Scholar
Pre-eminent status by Queensland Health
Rouse Fellowship, Royal Australian and New Zealand College of Radiologists
Teaching
Dr Porceddu has had a life-long commitment to teaching and is a supervisor and mentor to Doctor of Philosophy and Master of Philosophy candidates, Clinical Research Fellows, MBBS Honours students, resident, registrars and other allied health professionals.
Availability
- Professor Sandro Porceddu is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Science, Monash University
- Bachelor of Medicine and Surgery and Medical Science, Monash University
- Doctoral Diploma of Medicine, The University of Queensland
Research impacts
Dr Porceddu’s has been investigating methods to reduce the morbidity of treatment, improve cure rates and quality of life for cancer patients. He runs an active head and neck/skin cancer research program and is the principal investigator of numerous trials including an NHMRC-supported Randomised Phase III trial on head and neck skin cancer (POST TROG 05.01). In line with his research goals he has been examining the integration of radiation therapy and new technologies in the management of head and neck cancer and has received his Doctorate of Medicine (MD) on this topic with UQ. His current research on Positron Emission Tomography in the management of the neck following chemo-radiotherapy has been internationally recognised and incorporated into the USA National Comprehensive Cancer Network (NCCN) guidelines. He has been the recipient of over $3.91M in competitive funding, including one recently closed and two open NHMRC grants.
Works
Search Professor Sandro Porceddu’s works on UQ eSpace
2010
Journal Article
Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 no squamous cell carcinoma of the oral tongue
Brennan, Sinead, Corry, June, Kleid, Stephen, Porceddu, Sandro, Yuen, Kally, Rischin, Danny and Peters, Lester J. (2010). Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 no squamous cell carcinoma of the oral tongue. Head and Neck, 32 (2), 191-198. doi: 10.1002/hed.21167
2010
Book Chapter
Acute and late radiation therapy effects
Porceddu, Sandro V., Martin, Jarad M., O'Sullivan, Brian and Fay, Michael (2010). Acute and late radiation therapy effects. When cancer crosses disciplines: A physician's handbook. (pp. 179-200) edited by Monica Robotin, Ian Olver and Afaf Girgis. London, United Kingdom: Imperial College Press. doi: 10.1142/9781848163652_0008
2010
Conference Publication
Results of a prospective study of PET-directed management of the neck in node positive head and neck cancer following definitive radiotherapy with or without systemic therapy
Porceddu, S., Pryor, D., Burmeister, E., Burmeister, B., Poulsen, M., Foote, M., Panizza, B., Logan, J., McFarlane, D. and Coman, W. (2010). Results of a prospective study of PET-directed management of the neck in node positive head and neck cancer following definitive radiotherapy with or without systemic therapy. 52nd Annual Meeting of the American-Society-For-Radiation-Oncology, San Diego, CA United States, 31 October - 4 November 2010. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.ijrobp.2010.07.275
2009
Journal Article
Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation
Corry, June, Poon, Wendy, McPhee, Narelle, Milner, Alvin D., Cruickshank, Deborah, Porceddu, Sandro V., Rischin, Danny and Peters, Lester J. (2009). Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 31 (7), 867-876. doi: 10.1002/hed.21044
2009
Journal Article
Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer
Pryor, David I., Porceddu, Sandro V., Burmeister, Bryan H., Guminski, Alex, Thomson, Damien B., Shepherdson, Kristine and Poulsen, Michael (2009). Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiotherapy and Oncology, 90 (2), 172-176. doi: 10.1016/j.radonc.2008.09.018
2009
Journal Article
Results of a prospective PET-guided management of the neck study in node positive head and neck squamous cell carcinoma (HNSCC) following curative radiotherapy with or without concurrent chemotherapy
Porceddu, S. V., Pryor, D. I., Doughton, J., Burmeister, E., Burmeister, B. and Poulsen, M. G. (2009). Results of a prospective PET-guided management of the neck study in node positive head and neck squamous cell carcinoma (HNSCC) following curative radiotherapy with or without concurrent chemotherapy. Oral Oncology Supplement, 3 (1), 64-64. doi: 10.1016/j.oos.2009.06.110
2009
Conference Publication
The Effect of Radiotherapy Dose and Volume on Relapse in Merkel Cell Cancer of the Skin
Foote, M. C., Harvey, J., Porceddu, S., Dickie, G., Hewitt, S., Colquist, S., Zarate, D. and Poulsen, M. (2009). The Effect of Radiotherapy Dose and Volume on Relapse in Merkel Cell Cancer of the Skin. 51st Annual Meeting of the American-Society-for-Radiation-Oncology, Chicago, Il, United States, 1-5 November 2009. New York, NY, United States: Elsevier .
2009
Conference Publication
The emerging role of biomarker profiling and functional imaging for guidance of head and neck cancer management
Porceddu, S. V. (2009). The emerging role of biomarker profiling and functional imaging for guidance of head and neck cancer management. 2nd World Congress of the International-Academy-of-Oral-Oncology, Toronto, Canada, 8-11 July, 2009. AMSTERDAM: Elsevier; Pergamon. doi: 10.1016/j.oos.2009.06.055
2009
Conference Publication
Results of a prospective PET-guided management of the neck study in node positive head and neck squamous cell carcinoma (HNSCC) following curative radiotherapy with or without concurrent chemotherapy
PorcedduSV, PryorDI, DoughtonJ, BurmeisterE, BurmeisterBH and Poulsen, M. G. (2009). Results of a prospective PET-guided management of the neck study in node positive head and neck squamous cell carcinoma (HNSCC) following curative radiotherapy with or without concurrent chemotherapy. 2nd World Congress of the International Academy of Oral Oncology, Toronto, Canada, 8-11 July, 2009. AMSTERDAM: Elsevier; Pergamon. doi: 10.1016/j.oos.2009.06.110
2008
Journal Article
Role of functional imaging in head and neck squamous cell carcinoma: Fluorodeoxyglucose positron emission tomography and beyond
Porceddu, Sandro V., Burmeister, Bryan H. and Hicks, Rodney J. (2008). Role of functional imaging in head and neck squamous cell carcinoma: Fluorodeoxyglucose positron emission tomography and beyond. Hematology Oncology Clinics of North America, 22 (6), 1221-1238. doi: 10.1016/j.hoc.2008.08.009
2008
Journal Article
Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: A clinican's guide
Porceddu, S. V., Sidhom, M., Foote, M., Burmeister, E., Stoneley, A., Hawwari, B. El, Milross, C., Kenny, L., Poulsen, M. and Coman, W. B. (2008). Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: A clinican's guide. Journal of Medical Imaging and Radiation Oncology, 52 (5), 491-496. doi: 10.1111/j.1440-1673.2008.02001.x
2008
Journal Article
Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation
Corry, J., Poon, W., McPhee, N., Milner, A. D., Cruickshank, D., Porceddu, S. V., Rischin, D. and Peters, L. J. (2008). Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation. Journal of Medical Imaging and Radiation Oncology, 52 (5), 503-510. doi: 10.1111/j.1440-1673.2008.02003.x
2008
Journal Article
Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment - "hypo trial" - Authors letter of reply
Porceddu, Sandro V., Rosser, Brenda, Burmeister, Bryan H., Jones, Mark, Hickey, Brigid, Baumann, Kacy, Gogna, Kumar, Pullar, Andrew, Poulsen, Michael and Holt, Tanya (2008). Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment - "hypo trial" - Authors letter of reply. Radiotherapy and Oncology, 87 (2), 309-309. doi: 10.1016/j.radonc.2008.03.015
2008
Journal Article
Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone
Poulsen, M. G., RiddleB, KellerJ, PorcedduSV and TripconyL (2008). Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone. Radiotherapy and Oncology, 87 (2), 253-259. doi: 10.1016/j.radonc.2008.03.010
2007
Journal Article
Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment - "hypo trial"
Porceddu, Sandro V., Rosser, Brenda, Burmeister, Bryan H., Jones, Mark, Hickey, Brigid, Baumann, Kacy, Gogna, Kumar, Pullar, Andrew, Poulsen, Michael and Holt, Tanya (2007). Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment - "hypo trial". Radiotherapy and Oncology, 85 (3), 456-462. doi: 10.1016/j.radonc.2007.10.020
2007
Journal Article
In reference to locally advanced tonsillar squamous cell carcinoma: treatment approach revisited - Reply
Poulsen, Michael, Kingsley, Pamela A. and Porceddu, Sandro V. (2007). In reference to locally advanced tonsillar squamous cell carcinoma: treatment approach revisited - Reply. Laryngoscope, 117 (10), 1895-1895. doi: 10.1097/MLG.0b013e318123ee94
2007
Journal Article
Cutaneous head and beck squamous cell carcinoma metastatic to parotid and cervical lymph nodes
Veness, M., Porceddu, S.V., Palme, C. and Morgan, G. (2007). Cutaneous head and beck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head & Neck, 29 (7), 621-630. doi: 10.1002/hed.20576
2007
Journal Article
Locally advanced tonsillar squamous cell carcinoma: Treatment approach revisited
Poulsen, M., Porceddu, S. V., Kingsley, P. A., Tripcony, L and Coman, W (2007). Locally advanced tonsillar squamous cell carcinoma: Treatment approach revisited. Laryngoscope, 117 (1), 45-50. doi: 10.1097/01.mlg.0000243044.91193.32
2006
Journal Article
Head and neck cancer: past, present and future
Chin, David, Boyle, Glen M., Porceddu, Sandro, Theile, David R., Parsons, Peter G. and Coman, William B. (2006). Head and neck cancer: past, present and future. Expert Review of Anticancer Therapy, 6 (7), 1111-1118. doi: 10.1586/14737140.6.7.1111
2006
Journal Article
Prognostic significance of [F-18]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncolo
Rischin, D., Hicks, R. J., Fisher, R., Binns, D., Corry, J., Porceddu, S. and Peters, L. J. (2006). Prognostic significance of [F-18]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncolo. Journal of Clinical Oncology, 24 (13), 2098-2104. doi: 10.1200/JCO.2005.05.2878
Funding
Past funding
Supervision
Availability
- Professor Sandro Porceddu is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Completed supervision
-
2017
Master Philosophy
Pre-radiotherapy dental extractions and osteoradionecrosis: a retrospective analysis and cross-sectional study on quality of life
Associate Advisor
-
2012
Doctor Philosophy
Swallowing, nutrition, and patient-rated functional outcomes in head and neck cancer patients treated with altered fractionation radiotherapy
Associate Advisor
Other advisors: Professor Elizabeth Ward
Media
Enquiries
For media enquiries about Professor Sandro Porceddu's areas of expertise, story ideas and help finding experts, contact our Media team: